FDA Says Weight Loss Drug Lorcaserin May Increase Risk of Cancer

The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with …

| | | |

Review Sheds New Light on Gangrene Cases Linked to Patients on SGLT2 Diabetes Drugs

A new review of Fournier Gangrene cases associated with SGLT2 diabetes drugs conducted by researchers is shedding new light on the occurrence of …

| | |